StockNews.AI
ATNM
StockNews.AI
137 days

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Actinium

1. Investors with losses over $75,000 in ATNM should consult legal counsel. 2. A federal securities class action against Actinium Pharmaceuticals is underway.

2m saved
Insight
Article

FAQ

Why Bearish?

Legal challenges can deter investors and negatively affect stock value, similar to past such instances.

How important is it?

The reminder of a class action lawsuit indicates potential for financial liability and investor unrest.

Why Short Term?

Legal proceedings typically lead to immediate fluctuations in stock valuation, especially near deadlines.

Related Companies

VRTXICPTCLVS
NEW YORK CITY, NY / ACCESS Newswire / April 4, 2025 / Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Actinium To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Actinium between October 31, 2022 and August 2, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Actinium Pharmaceuticals, Inc. ("Actinium" or the "Company") (NYSE:ATNM) and reminds investors of the May 26, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Related News